Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 411

1.

A Heterozygous ABCB4, RUNDC3B, and ABCB1 Deletion Associated With Severe Cholestatic Liver Disease in Adulthood.

Terziroli Beretta-Piccoli B, Thompson R, Foskett P, Cerny A, Merlo E, Vergani D, Rougemont AL, Moix I, Mieli-Vergani G, Morris M.

Hepatology. 2019 May 24. doi: 10.1002/hep.30783. [Epub ahead of print] No abstract available.

PMID:
31127640
2.

Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents.

Terziroli Beretta-Piccoli B, Di Bartolomeo C, Deleonardi G, Grondona AG, Silvestri T, Tesei C, Melidona L, Cerny A, Mertens J, Semmo N, Semela D, Moradpour D, Mieli-Vergani G, Vergani D, Muratori L; Swiss Hepatitis C Cohort Study.

J Autoimmun. 2019 Aug;102:89-95. doi: 10.1016/j.jaut.2019.04.019. Epub 2019 Apr 30.

PMID:
31047768
3.

De novo autoimmune hepatitis -is this different in adults compared to children?

Kerkar N, Vergani D.

J Autoimmun. 2018 Dec;95:26-33. doi: 10.1016/j.jaut.2018.10.023. Epub 2018 Nov 3. Review.

PMID:
30396746
4.

The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.

Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D.

J Autoimmun. 2018 Dec;95:144-158. doi: 10.1016/j.jaut.2018.10.004. Epub 2018 Oct 23. Review.

PMID:
30366656
5.

Autoimmune sclerosing cholangitis: Evidence and open questions.

Terziroli Beretta-Piccoli B, Vergani D, Mieli-Vergani G.

J Autoimmun. 2018 Dec;95:15-25. doi: 10.1016/j.jaut.2018.10.008. Epub 2018 Oct 23. Review.

PMID:
30366655
6.

Juvenile autoimmune hepatitis: A comprehensive review.

Sokollik C, McLin VA, Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G.

J Autoimmun. 2018 Dec;95:69-76. doi: 10.1016/j.jaut.2018.10.007. Epub 2018 Oct 19. Review.

PMID:
30344030
7.

Autoimmune liver disease serology in acute hepatitis E virus infection.

Terziroli Beretta-Piccoli B, Ripellino P, Gobbi C, Cerny A, Baserga A, Di Bartolomeo C, Bihl F, Deleonardi G, Melidona L, Grondona AG, Mieli-Vergani G, Vergani D, Muratori L; Swiss Autoimmune Hepatitis Cohort Study Group.

J Autoimmun. 2018 Nov;94:1-6. doi: 10.1016/j.jaut.2018.07.006. Epub 2018 Jul 7.

PMID:
30336842
8.

De novo unbalanced translocations have a complex history/aetiology.

Bonaglia MC, Kurtas NE, Errichiello E, Bertuzzo S, Beri S, Mehrjouy MM, Provenzano A, Vergani D, Pecile V, Novara F, Reho P, Di Giacomo MC, Discepoli G, Giorda R, Aldred MA, Santos-Rebouças CB, Goncalves AP, Abuelo DN, Giglio S, Ricca I, Franchi F, Patsalis P, Sismani C, Morí MA, Nevado J, Tommerup N, Zuffardi O.

Hum Genet. 2018 Oct;137(10):817-829. doi: 10.1007/s00439-018-1941-9. Epub 2018 Oct 1.

PMID:
30276538
9.

Real-world management of juvenile autoimmune liver disease.

de Boer YS, Liberal R, Vergani D, Mieli-Vergani G.

United European Gastroenterol J. 2018 Aug;6(7):1032-1038. doi: 10.1177/2050640618768922. Epub 2018 Mar 30.

10.

The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?

Smyk DS, Mavropoulos A, Mieli-Vergani G, Vergani D, Lenzi M, Bogdanos DP.

Can J Gastroenterol Hepatol. 2018 Jun 26;2018:8197937. doi: 10.1155/2018/8197937. eCollection 2018. Review.

11.

Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis.

Gragnani L, Cerretelli G, Lorini S, Steidl C, Giovannelli A, Monti M, Petraccia L, Sadalla S, Urraro T, Caini P, Xheka A, Simone A, Arena U, Matucci-Cerinic M, Vergani D, Laffi G, Zignego AL.

Aliment Pharmacol Ther. 2018 Aug;48(4):440-450. doi: 10.1111/apt.14845. Epub 2018 Jun 28.

PMID:
29952013
12.

Should Giant Cell Hepatitis With Autoimmune Haemolythic Anaemia Be Considered a Paediatric Autoimmune Liver Disease?

Mieli-Vergani G, Vergani D.

J Pediatr Gastroenterol Nutr. 2018 May;66(5):e138. doi: 10.1097/MPG.0000000000001911. No abstract available.

PMID:
29688999
13.

Autoimmune hepatitis.

Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, Lohse AW, Montano-Loza AJ.

Nat Rev Dis Primers. 2018 Apr 12;4:18017. doi: 10.1038/nrdp.2018.17. Review.

PMID:
29644994
14.

Chapter 6.2. Immune Function-related Liver Disease and ESPGHAN's Contribution to the Advancement of Science in the Last 3 Decades.

Dhawan A, Mieli-Vergani G, Vergani D, Hadzic N, Maggiore G.

J Pediatr Gastroenterol Nutr. 2018 Apr;66 Suppl 1:S122-S128. doi: 10.1097/MPG.0000000000001916. No abstract available.

PMID:
29596183
15.

Chapter 6. ESPGHAN's Contributions to Paediatric Hepatology.

Burdelski M, Sokal E, Nannini P, Dhawan A, Mieli-Vergani G, Vergani D, Hadzic N, Maggiore G, Vajro P, Paolella G, Alfano G, Houwen R, Kelly D.

J Pediatr Gastroenterol Nutr. 2018 Apr;66 Suppl 1:S116. doi: 10.1097/MPG.0000000000001916. No abstract available.

PMID:
29596180
16.

Atovaquone/proguanil-induced autoimmune-like hepatitis.

Terziroli Beretta-Piccoli B, Mieli-Vergani G, Bertoli R, Mazzucchelli L, Nofziger C, Paulmichl M, Vergani D.

Hepatol Commun. 2017 May 8;1(4):293-298. doi: 10.1002/hep4.1039. eCollection 2017 Jun.

17.

Should Giant Cell Hepatitis With Autoimmune Hemolythic Anemia Be Considered A Pediatric Autoimmune Liver Disease?

Mieli-Vergani G, Vergani D.

J Pediatr Gastroenterol Nutr. 2018 Feb 1. doi: 10.1097/MPG.0000000000001911. [Epub ahead of print] No abstract available.

PMID:
29394217
18.

Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement.

Mieli-Vergani G, Vergani D, Baumann U, Czubkowski P, Debray D, Dezsofi A, Fischler B, Gupte G, Hierro L, Indolfi G, Jahnel J, Smets F, Verkade HJ, Hadžić N.

J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):345-360. doi: 10.1097/MPG.0000000000001801.

PMID:
29356770
19.

Diagnosis and Management of Paediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement.

Mieli-Vergani G, Vergani D, Baumann U, Czubkowski P, Debray D, Dezsofi A, Fischler B, Gupte G, Hierro L, Indolfi G, Jahnel J, Smets F, Verkade HJ, Hadzic N.

J Pediatr Gastroenterol Nutr. 2017 Nov 3. doi: 10.1097/MPG.0000000000001801. [Epub ahead of print]

PMID:
29112085
20.

Spectroscopic identification of r-process nucleosynthesis in a double neutron-star merger.

Pian E, D'Avanzo P, Benetti S, Branchesi M, Brocato E, Campana S, Cappellaro E, Covino S, D'Elia V, Fynbo JPU, Getman F, Ghirlanda G, Ghisellini G, Grado A, Greco G, Hjorth J, Kouveliotou C, Levan A, Limatola L, Malesani D, Mazzali PA, Melandri A, Møller P, Nicastro L, Palazzi E, Piranomonte S, Rossi A, Salafia OS, Selsing J, Stratta G, Tanaka M, Tanvir NR, Tomasella L, Watson D, Yang S, Amati L, Antonelli LA, Ascenzi S, Bernardini MG, Boër M, Bufano F, Bulgarelli A, Capaccioli M, Casella P, Castro-Tirado AJ, Chassande-Mottin E, Ciolfi R, Copperwheat CM, Dadina M, De Cesare G, Di Paola A, Fan YZ, Gendre B, Giuffrida G, Giunta A, Hunt LK, Israel GL, Jin ZP, Kasliwal MM, Klose S, Lisi M, Longo F, Maiorano E, Mapelli M, Masetti N, Nava L, Patricelli B, Perley D, Pescalli A, Piran T, Possenti A, Pulone L, Razzano M, Salvaterra R, Schipani P, Spera M, Stamerra A, Stella L, Tagliaferri G, Testa V, Troja E, Turatto M, Vergani SD, Vergani D.

Nature. 2017 Nov 2;551(7678):67-70. doi: 10.1038/nature24298. Epub 2017 Oct 16.

PMID:
29094694
21.

Serology in autoimmune hepatitis: A clinical-practice approach.

Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D.

Eur J Intern Med. 2018 Feb;48:35-43. doi: 10.1016/j.ejim.2017.10.006. Epub 2017 Oct 19. Review.

PMID:
29056396
22.

Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.

Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D.

World J Gastroenterol. 2017 Sep 7;23(33):6030-6048. doi: 10.3748/wjg.v23.i33.6030. Review.

23.

Anti-TNFα Treatment in Children and Adolescents With Combined Inflammatory Bowel Disease and Autoimmune Liver Disease.

Nedelkopoulou N, Vadamalayan B, Vergani D, Mieli-Vergani G.

J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):100-105. doi: 10.1097/MPG.0000000000001759.

PMID:
28953529
24.

Autoimmunhepatitis: das Wichtigste für die Praxis.

Terziroli Beretta-Piccoli B, Vergani D, Mieli-Vergani G.

Ther Umsch. 2017 Jul;74(3):115-121. doi: 10.1024/0040-5930/a000894. Review. German. No abstract available.

PMID:
28777048
25.

SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type.

Errichiello E, Mustafa N, Vetro A, Notarangelo LD, de Jonge H, Rinaldi B, Vergani D, Giglio SR, Morbini P, Zuffardi O.

J Pathol. 2017 Sep;243(1):9-15. doi: 10.1002/path.4926. Epub 2017 Jul 25.

26.

Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis.

Liberal R, Grant CR, Yuksel M, Graham J, Kalbasi A, Ma Y, Heneghan MA, Mieli-Vergani G, Vergani D, Longhi MS.

Hepatology. 2017 Nov;66(5):1570-1584. doi: 10.1002/hep.29307. Epub 2017 Oct 3.

27.

Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda.

Sebode M, Hartl J, Vergani D, Lohse AW; International Autoimmune Hepatitis Group (IAIHG).

Liver Int. 2018 Jan;38(1):15-22. doi: 10.1111/liv.13458. Epub 2017 May 18. Review.

PMID:
28432836
28.

The Riddle of Juvenile Sclerosing Cholangitis.

Mieli-Vergani G, Vergani D.

Hepatology. 2017 Aug;66(2):315-317. doi: 10.1002/hep.29208. Epub 2017 Jun 26. No abstract available.

PMID:
28407274
29.

Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.

Grant CR, Holder BS, Liberal R, Heneghan MA, Ma Y, Mieli-Vergani G, Vergani D, Longhi MS.

Clin Exp Immunol. 2017 Jul;189(1):71-82. doi: 10.1111/cei.12956. Epub 2017 Mar 27.

30.

MCM5: a new actor in the link between DNA replication and Meier-Gorlin syndrome.

Vetro A, Savasta S, Russo Raucci A, Cerqua C, Sartori G, Limongelli I, Forlino A, Maruelli S, Perucca P, Vergani D, Mazzini G, Mattevi A, Stivala LA, Salviati L, Zuffardi O.

Eur J Hum Genet. 2017 May;25(5):646-650. doi: 10.1038/ejhg.2017.5. Epub 2017 Feb 15.

31.

Cutting edge issues in autoimmune hepatitis.

Liberal R, Krawitt EL, Vierling JM, Manns MP, Mieli-Vergani G, Vergani D.

J Autoimmun. 2016 Dec;75:6-19. doi: 10.1016/j.jaut.2016.07.005. Epub 2016 Aug 5. Review.

PMID:
27502148
32.

Mouse model of primary biliary cholangitis with a striking female predominance: A new powerful research tool.

Vergani D, Mieli-Vergani G.

Hepatology. 2016 Oct;64(4):1024-7. doi: 10.1002/hep.28718. Epub 2016 Aug 2. No abstract available.

PMID:
27388433
33.

Human identification by lice: A Next Generation Sequencing challenge.

Pilli E, Agostino A, Vergani D, Salata E, Ciuna I, Berti A, Caramelli D, Lambiase S.

Forensic Sci Int. 2016 Sep;266:e71-e78. doi: 10.1016/j.forsciint.2016.05.006. Epub 2016 May 16.

PMID:
27289564
34.

Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation.

Liberal R, Vergani D, Mieli-Vergani G.

Liver Transpl. 2016 Sep;22(9):1275-83. doi: 10.1002/lt.24490. Epub 2016 Aug 1. Review.

35.

Contemporary issues and future directions in autoimmune hepatitis.

Liberal R, Mieli-Vergani G, Vergani D.

Expert Rev Gastroenterol Hepatol. 2016 Oct;10(10):1163-1174. doi: 10.1080/17474124.2016.1193004. Epub 2016 Jun 3.

PMID:
27215278
36.

CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease.

Liberal R, Grant CR, Ma Y, Csizmadia E, Jiang ZG, Heneghan MA, Yee EU, Mieli-Vergani G, Vergani D, Robson SC, Longhi MS.

J Autoimmun. 2016 Aug;72:102-12. doi: 10.1016/j.jaut.2016.05.005. Epub 2016 May 20.

37.

Autoimmune hepatitis: From mechanisms to therapy.

Liberal R, Mieli-Vergani G, Vergani D.

Rev Clin Esp. 2016 Oct;216(7):372-383. doi: 10.1016/j.rce.2016.04.003. Epub 2016 May 6. English, Spanish.

PMID:
27161382
38.

Paediatric Autoimmune Liver Disease.

Liberal R, Vergani D, Mieli-Vergani G.

Dig Dis. 2015;33 Suppl 2:36-46. doi: 10.1159/000440708. Epub 2015 Dec 7.

PMID:
26641670
39.

Sclerosing Cholangitis in Children and Adolescents.

Mieli-Vergani G, Vergani D.

Clin Liver Dis. 2016 Feb;20(1):99-111. doi: 10.1016/j.cld.2015.08.008. Epub 2015 Oct 6. Review.

PMID:
26593293
40.

Update on Autoimmune Hepatitis.

Liberal R, Vergani D, Mieli-Vergani G.

J Clin Transl Hepatol. 2015 Mar;3(1):42-52. doi: 10.14218/JCTH.2014.00032. Epub 2015 Mar 15. Review.

41.

Acute alcoholic hepatitis and cellular Th1 immune responses to alcohol dehydrogenase.

Blackmore LJ, Ryan JM, Huang X, Hussain M, Triantafyllou E, Vergis N, Vijay GM, Antoniades CG, Thursz MR, Jassem W, Vergani D, Shawcross DL, Ma Y.

Lancet. 2015 Feb 26;385 Suppl 1:S22. doi: 10.1016/S0140-6736(15)60337-3.

PMID:
26312844
42.

A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.

Yuksel M, Wang Y, Tai N, Peng J, Guo J, Beland K, Lapierre P, David C, Alvarez F, Colle I, Yan H, Mieli-Vergani G, Vergani D, Ma Y, Wen L.

Hepatology. 2015 Nov;62(5):1536-50. doi: 10.1002/hep.27998. Epub 2015 Aug 25.

43.

In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression.

Liberal R, Grant CR, Holder BS, Cardone J, Martinez-Llordella M, Ma Y, Heneghan MA, Mieli-Vergani G, Vergani D, Longhi MS.

Hepatology. 2015 Sep;62(3):863-75. doi: 10.1002/hep.27884. Epub 2015 Jun 18.

PMID:
25953611
44.

Autoimmune hepatitis--Update 2015.

Manns MP, Lohse AW, Vergani D.

J Hepatol. 2015 Apr;62(1 Suppl):S100-11. doi: 10.1016/j.jhep.2015.03.005. Review. No abstract available.

45.

Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease.

Liberal R, Grant CR, Longhi MS, Mieli-Vergani G, Vergani D.

IUBMB Life. 2015 Feb;67(2):88-97. doi: 10.1002/iub.1349. Epub 2015 Apr 8. Review.

46.

Autoimmune liver disease in Asian children.

Mieli-Vergani G, Vergani D.

Hepatol Int. 2015 Apr;9(2):157-60. doi: 10.1007/s12072-014-9602-0. Epub 2015 Jan 6. No abstract available.

PMID:
25788190
47.

Th-17 cells infiltrate the liver in human biliary atresia and are related to surgical outcome.

Hill R, Quaglia A, Hussain M, Hadzic N, Mieli-Vergani G, Vergani D, Davenport M.

J Pediatr Surg. 2015 Aug;50(8):1297-303. doi: 10.1016/j.jpedsurg.2015.02.005. Epub 2015 Feb 14.

PMID:
25783388
48.

Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions.

Grant CR, Liberal R, Mieli-Vergani G, Vergani D, Longhi MS.

Autoimmun Rev. 2015 Feb;14(2):105-16. doi: 10.1016/j.autrev.2014.10.012. Epub 2014 Oct 16. Review. Erratum in: Autoimmun Rev. 2015 Sep;14(9):845-6.

PMID:
25449680
49.

Autoimmune hepatitis.

Longhi MS, Mieli-Vergani G, Vergani D.

Curr Pediatr Rev. 2014;10(4):268-74. Review.

PMID:
25403636
50.

Towards the serological diagnosis of primary biliary cirrhosis.

Vergani D.

Liver Int. 2015 Feb;35(2):299-301. doi: 10.1111/liv.12732. No abstract available.

PMID:
25385263

Supplemental Content

Loading ...
Support Center